Schizophrenia – Drug Pipeline Analysis and Market Forecasts to 2015 -Aarkstore Enterprise

Nov 112010

Free Online Articles Directory

Why Submit Articles?
Top Authors
Top Articles
FAQ
AB Answers

Publish Article

0 && $.browser.msie ) {
var ie_version = parseInt($.browser.version);
if(ie_version Hello Guest
Login

Email

Password

Remember me?
Lost Password?

Home Page > Health > Medicine > Schizophrenia – Drug Pipeline Analysis and Market Forecasts to 2015 -Aarkstore Enterprise

Schizophrenia – Drug Pipeline Analysis and Market Forecasts to 2015 -Aarkstore Enterprise

Edit Article |

Posted: May 20, 2010 |Comments: 0

]]>

Syndicate this Article

Copy to clipboard

Schizophrenia – Drug Pipeline Analysis and Market Forecasts to 2015 -Aarkstore Enterprise

By: Minal

About the Author

Minal H
SEO
vinod.minal@gmail.com
http://www.aarkstore.com

(ArticlesBase SC #2413109)

Article Source: http://www.articlesbase.com/ – Schizophrenia – Drug Pipeline Analysis and Market Forecasts to 2015 -Aarkstore Enterprise

The industry analysis specialist, has released a new report, “Schizophrenia – Drug Pipeline Analysis and Market Forecasts to 2015″. The report is an essential source of information and analysis on the global schizophrenia market. The report identifies the key trends shaping and driving the global schizophrenia market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to cause significant shifts in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global schizophrenia sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
GlobalData estimated the global schizophrenia market to be valued at .9 billion in 2008. It is forecast to grow by 1.3% annually for the next seven years to reach .2 billion by 2015.

This low growth is primarily attributed to release of generics of some of the leading products as well as weak pipeline candidates. High incidence and prevalence rate of disease will act as a driver for the market growth; however this will not be able to compensate for restriction caused by barriers as they are stronger in impact. GlobalData analyzed that the global schizophrenia market is moderately served with current product options and significant scope available to new entrants that would capture value from underserved segments.
GlobalData analyzed that the global schizophrenia market is heading toward static competitive landscape. As pipeline candidates are not offering clear clinical benefits compared to current products in term of prolonged remission and high safety profile, the launch of these molecules in near future will not be able to bring significant change in competitive landscape. Designing curable products with high safety profile is one of key challenges of this market and coming up with a product of high efficacy and safety profile will be proved to be a future blockbuster.

Scope

The scope of the report includes:

- Annualized global schizophrenia market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include dopamine serotonin receptor targetters, nicotinic acetylcholine receptors targetters, NK receptors targetters and NMDA receptors targetters.
- Analysis of the current and future market competition in the global schizophrenia market. Key market players covered are AstraZeneca PLC, Pfizer Inc., GSK, J&J and Merck & Co.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with schizophrenia.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global schizophrenia market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global schizophrenia market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global schizophrenia market landscape? – Identify, understand and capitalize.” ,000 ,000 ,000 GDHCPRT008 Pharmaceuticals and Healthcare Market forecast, revenues, unmet need, drivers, barriers, pharma, clinical trials, marketed products, pipeline, promising drugs, future players, key companies, strategic competitor assessment, market characterization, implications for future market, mechanism of action, dopamine serotonin receptor targetters, nicotinic acetylcholine receptors targetters, NK receptors targetters and NMDA receptors targetters

For more information,please visit:

http://www.aarkstore.com/reports/Schizophrenia-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2015-40576.html

Retrieved from “http://www.articlesbase.com/medicine-articles/schizophrenia-drug-pipeline-analysis-and-market-forecasts-to-2015-aarkstore-enterprise-2413109.html”

(ArticlesBase SC #2413109)

Minal -
About the Author:

Minal H
SEO
vinod.minal@gmail.com
http://www.aarkstore.com

]]>

Rate this Article

1
2
3
4
5

vote(s)
0 vote(s)

Feedback
RSS
Print
Email
Re-Publish

Source: http://www.articlesbase.com/medicine-articles/schizophrenia-drug-pipeline-analysis-and-market-forecasts-to-2015-aarkstore-enterprise-2413109.html

Article Tags:
schizophrenia, drug, pipeline, analysis, market, forecasts, research, report, business, industry, information, automotive, banking, finance, food, beverages, technology, biomass, books, conference, company profiles, country

Latest Medicine Articles
More from Minal

Understanding BMI and Xenical for better weight loss

Body mass index (BMI) is an important measurement to find out if an individual is underweight, normal-weight, overweight or obese. If your BMI is 27 or more, you are overweight and your condition may soon turn worse if you do not work on losing the excess pounds. Xenical orlistat can help you maintain a healthy weight. Read on to find out more.

By:
sally gomesl